Windham-Bannister Susan Richards has filed 4 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 80000 shares of Humacyte, Inc. ($HUMA) on June 12, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2025 | Humacyte, Inc. | $HUMA | Windham-Bannister Susan Richards | Director | A | Stock Options (right to buy) | 80000 | $0.00 | 80,000.0000 | 155,118,816 | 9999.99% | 0.05% |
| June 27, 2024 | Aridis Pharmaceuticals, Inc. | $ARDS | Windham-Bannister Susan Richards | Director | A | Stock options | 200000 | $0.00 | 261,000.0000 | 37,428,943 | 327.87% | 0.53% |
| June 13, 2024 | Humacyte, Inc. | $HUMA | Windham-Bannister Susan Richards | Director | A | Stock Options (right to buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2023 | Humacyte, Inc. | $HUMA | Windham-Bannister Susan Richards | Director | A | Stock Options (right to buy) | 8500 | $0.00 | 8,500.0000 | 0 | 9999.99% | 0.00% |